- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01450852
Strength Training Induced Alterations in Markers of Immune Function
Exercise has been used to help prevent or slow the progression of inflammation-related disease; however, the mechanism by which this activity may lower concentrations of inflammatory markers remains unclear. The melanocortin receptors 1,3 and 5 (MC1R, MC3R and MC5R) have been shown to function in an anti-inflammatory manner and have the potential to mediate the positive immune adaptations associated with regular physical activity.
Preliminary data suggest that MC3R gene expression increases in whole blood after chronic exercise training. The primary aim of the current study is to explore whether this change in gene expression translates into alterations in MC1R, MC3R, or MC5R monocyte surface expression. The secondary aim is to examine the relationship between surface expression of these receptors and circulating inflammatory profiles.
The investigators will recruit 42 untrained, healthy males and females aged 18-35 yrs. Half of the group will be placed on an exercise program for 15 weeks. The other half will serve as untrained control subjects. In addition to basic anthropometric measures, the investigators will measure concentrations of inflammatory and anti-inflammatory cytokines (ELISA) and cell surface expression of MC1R, MC3R, and MC5R on monocytes (flow cytometry).
Study Overview
Detailed Description
Abstract:
Chronic exercise reduces inflammation, but the mechanisms involved are unclear. Recent studies have shown that stimulation of melanocortin 1 and 3 receptors (MC1R and MC3R) on immune cells increases anti-inflammatory cytokine production. PURPOSE: To examine the influence of 12 weeks of resistance training (RT) on body composition, monocyte cell-surface expression of MC1R and MC3R and circulating markers of inflammation. METHODS: Healthy, active males and females (age 20-27 yr) were recruited into a RT group (RE; n = 23) and an active control group (AC; n = 19). RE completed 12 weeks of progressive, periodized RT 3d/wk while AC maintained normal activity habits. Measures of body composition (DXA) were taken and blood was collected prior to (PRE) and following the intervention period (POST). Blood samples were analyzed for monocyte cell-surface expression MC1R, MC3R, MC5R and C-reactive protein (CRP) and the plasma cytokines interleukin 6 (IL-6) and interleukin 10 (IL-10) using flow cytometry and ELISAs respectively.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70803
- Louisiana State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All Participants Must be Healthy
- The Strength Training Group Members Must Be Approved For Participation by a Licensed MD
Exclusion Criteria:
- Females may not be pregnant
- Unhealthy participants (those with existing conditions)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Strength Training
The strength training group completed 12 weeks of progressive, periodized resistance training 3d/wk.
|
Each Member of this group completed 12 weeks of progressive, periodized resistance training for 3d/wk.
|
|
No Intervention: Active Control Group
The active control group was instructed to maintain normal activity and eating habits.
They participated in all pre and post intervention measures.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Melanocortin 1 Receptor Expression on Monocytes
Time Frame: Before and After 12 Week of Intervention Period
|
Blood samples were analyzed for monocyte cell-surface expression of the melanocortin 1 receptor using flow cytometry.
Pre samples were collected in Jan. 2010 and post samples were collected in May 2010 from all subjects.
|
Before and After 12 Week of Intervention Period
|
|
Plasma CRP
Time Frame: Before and After the 12 Week Intervention Period
|
Blood samples were analyzed for C-reactive protein using ELISA.
Pre samples were collected in Jan. 2010 and post samples were collected in May 2010 from all subjects.
|
Before and After the 12 Week Intervention Period
|
|
Body Composition (Fat Tissue Amount)
Time Frame: Before and After the 12 Week Intervention Period
|
Body composition was assessed using DXA.
Pre measures were completed in Jan. 2010 and post measures were completed in May 2010 for all subjects.
|
Before and After the 12 Week Intervention Period
|
|
Plasma IL-6
Time Frame: Before and After the 12 Week Intervention Period
|
Blood samples were analyzed for IL-6 using ELISA.
Pre samples were collected in Jan. 2010 and post samples were collected in May 2010 from all subjects.
|
Before and After the 12 Week Intervention Period
|
|
Plasma IL-10
Time Frame: Before and After the 12 Week Intervention Period
|
Blood samples were analyzed for IL-10 using ELISA.
Pre samples were collected in Jan. 2010 and post samples were collected in May 2010 from all subjects.
|
Before and After the 12 Week Intervention Period
|
|
Melanocortin 3 Receptor Cell Surface Expression on Monocytes
Time Frame: Before and After the 12 Week Intervention Period
|
Blood samples were analyzed for monocyte cell-surface expression of the melanocortin 3 receptor using flow cytometry.
Pre samples were collected in Jan. 2010 and post samples were collected in May 2010 from all subjects.
|
Before and After the 12 Week Intervention Period
|
|
Melanocortin 5 Receptor Cell Surface Expression on Monocytes
Time Frame: Before and After the 12 Week Intevention Period
|
Blood samples were analyzed for monocyte cell-surface expression of the melanocortin 5 receptor using flow cytometry.
Pre samples were collected in Jan. 2010 and post samples were collected in May 2010 from all subjects.
|
Before and After the 12 Week Intevention Period
|
Collaborators and Investigators
Investigators
- Principal Investigator: Laura K Stewart, PhD, Louisiana State University Health Sciences Center in New Orleans
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LSU-IRB # 3005
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammation
-
University of EdinburghUmeå UniversityCompletedSystemic Inflammation | Respiratory InflammationSweden
-
University of AarhusAarhus University Hospital; University of CopenhagenCompletedSystemic Inflammation | Airway InflammationDenmark
-
Sykehuset TelemarkRikshospitalet University Hospital; Helse Sor-OstCompletedAirway Inflammation | Peripheral Blood Inflammation Markers | Cement Dust ExposureNorway
-
Center for Research and Innovation Viña Concha...Universidad Católica del MauleNot yet recruitingInflammaging | Antioxidant Status, Inflammation | Inflammation Biomarkers | Antioxidant Capabilities | Cardiometabolic Health IndicatorsChile
-
University of NebraskaNot yet recruiting
-
Central Hospital, Nancy, FranceRecruiting
-
Oral Science International Inc.AdvarraNot yet recruiting
-
University of NebraskaCompletedPeriodontal InflammationUnited States
-
University of California, DavisCompleted
-
Università degli Studi di BresciaCompletedVitreous Inflammation
Clinical Trials on Strength Training
-
University of FloridaCompleted
-
University of AarhusUnknownOsteoarthritis, KneeDenmark
-
Universidad Autónoma de Manizales, ColombiaCompletedFemale | Volleyball | PlayerColombia
-
Norwegian University of Science and TechnologyCompleted
-
Lislei Jorge PatrizziCompleted
-
Eunice Kennedy Shriver National Institute of Child...Shriners Hospitals for Children; University of DelawareUnknownSpastic Diplegic Cerebral PalsyUnited States
-
University of VigoNot yet recruitingPatients | Cancer Survivors | NeoplamsSpain
-
Christian DallCompletedHeart Failure | Ischemic Heart Disease | Heart Transplant RecipientsDenmark
-
Isra UniversityCompleted
-
Vrije Universiteit BrusselRecruitingHealthy Aged VolunteersBelgium